Application 071937
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VINCRISTINE SULFATE | VINCRISTINE SULFATE | Injectable; Injection | 5MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VinCRIStine Sulfate | VINCRISTINE SULFATE | Hospira, Inc. | b22e4c8e-dbe1-4d4b-a026-e1812974071c | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | VinCRIStine Sulfate VINCRISTINE SULFATE |
| VinCRIStine Sulfate | VINCRISTINE SULFATE | Hospira, Inc. | 49596de6-ab18-49d1-9e5b-30968fc21c36 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | VinCRIStine Sulfate VINCRISTINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.